Related references
Note: Only part of the references are listed.Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia
Hong Peng Jia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system
Daniel W. Lambert et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Functional angiotensin-converting enzyme 2 is expressed in human cardiac myofibroblasts
Jodie L. Guy et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor
Rebecca A. Lew et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Detection of soluble angiotensin-converting enzyme 2 in heart failure
Slava Epelman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
The ADAM metalloproteinases
Dylan R. Edwards et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry
Shiori Haga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain
Daniel W. Lambert et al.
FEBS LETTERS (2008)
The transmembrane domain of TACE regulates protein ectodomain shedding
Xiaojin Li et al.
CELL RESEARCH (2007)
The emerging role of ACE2 in physiology and disease
I. Hamming et al.
JOURNAL OF PATHOLOGY (2007)
Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II
Hossam A. Shaltout et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study
Gillian I. Rice et al.
HYPERTENSION (2006)
Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice
Susan B. Gurley et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
ACE2: A novel therapeutic target for cardiovascular diseases
S Der Sarkissian et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2006)
Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects
M Iwata et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells
FJ Warner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
F Li et al.
SCIENCE (2005)
Tumor necrosis factor-α convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)
DW Lambert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Y Imai et al.
NATURE (2005)
L-selectin: mechanisms and physiological significance of ectodomain cleavage
DM Smalley et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes
A Diwan et al.
CIRCULATION (2004)
Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor
H Hofmann et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Loss of ectodomain shedding due to mutations in the metalloprotease and cysteine-rich/disintegrin domains of the tumor necrosis factor-α converting enzyme (TACE)
XJ Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cloning and characterization of a secreted form of angiotensin-converting enzyme 2
MJ Huentelman et al.
REGULATORY PEPTIDES (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
Impaired trafficking and activation of tumor necrosis factor-α-converting enzyme in cell mutants defective in protein ectodomain shedding
A Borroto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-α converting enzyme and of an alternatively translated polypeptide
HZ Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The ADAMs family of metalloproteases: multidomain proteins with multiple functions
DF Seals et al.
GENES & DEVELOPMENT (2003)
Metalloprotease-mediated GH receptor proteolysis and GHBP shedding - Determination of extracellular domain stem region cleavage site
XD Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors
NA Dales et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
The active site of a zinc-dependent metalloproteinase influences the computed pKa of ligands coordinated to the catalytic zinc ion
JB Cross et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Angiotensin-converting enzyme 2 is an essential regulator of heart function
MA Crackower et al.
NATURE (2002)
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase
C Vickers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tumor necrosis factor-alpha converting enzyme
RA Black
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2002)
A human homolog of angiotensin-converting enzyme - Cloning and functional expression as a captopril-insensitive carboxypeptidase
SR Tipnis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9
M Donoghue et al.
CIRCULATION RESEARCH (2000)
Functional analysis of the domain structure of tumor necrosis factor-α converting enzyme
P Reddy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)